TG Therapeutics | TGTX - EPS Earnings Per Share

Stock Price
28.50
Daily Change
0.08 0.28%
Monthly
-3.52%
Yearly
-7.20%
Q1 Forecast
27.97

TG Therapeutics reported $2.43 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 0.33 0.15 Mar/03 2026
FY2025Q3 Sep/2025 2.43 0.25 0.02 Nov/03 2025
FY2025Q2 Jun/2025 0.17 0.20 0.04 Aug/04 2025
FY2025Q1 Mar/2025 0.03 0.15 -0.07 May/05 2025
FY2024Q4 Dec/2024 0.15 0.08 -0.09 Mar/03 2025




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Alaunos Therapeutics USD -0.53 0.07 Sep/2025
Amgen USD 5.29 0.35 Dec/2025
Ardelyx USD 0 0.08 Sep/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
Bayer EUR 0.57 0.66 Sep/2025
Biogen USD 1.99 2.82 Dec/2025
Corcept Therapeutics USD 0.16 0.13 Sep/2025
Curis USD -2.03 0.02 Jun/2024
Gilead Sciences USD 1.86 0.61 Dec/2025
J&J USD 2.46 0.34 Dec/2025
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Novartis USD 2.04 0.38 Sep/2025
Novavax USD -0.76 1.76 Sep/2024
PTC Therapeutics USD 0.2 1.03 Sep/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
TG Therapeutics USD 2.43 2.26 Sep/2025
Verastem USD -0.6 0.66 Sep/2024
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025